en
Scientific article
English

Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials

Published inAnnals of the rheumatic diseases, vol. 69, no. 10, p. 1756-1761
Publication date2010
Abstract

Tumour necrosis factor (TNF) blockers are known to increase the risk of serious infections in rheumatoid arthritis. Despite wide use of TNF blockers in ankylosing spondylitis (AS), the infection risk has never been evaluated in this disease.

Keywords
  • Antirheumatic Agents/adverse effects
  • Humans
  • Opportunistic Infections/complications/epidemiology
  • Randomized Controlled Trials as Topic
  • Risk Assessment/methods
  • Spondylitis, Ankylosing/complications/drug therapy/epidemiology
  • Tumor Necrosis Factor-alpha/antagonists & inhibitors
Citation (ISO format)
FOUQUE-AUBERT, Anne et al. Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials. In: Annals of the rheumatic diseases, 2010, vol. 69, n° 10, p. 1756–1761. doi: 10.1136/ard.2008.098822
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0003-4967
545views
0downloads

Technical informations

Creation11/28/2013 5:57:00 PM
First validation11/28/2013 5:57:00 PM
Update time03/14/2023 8:46:10 PM
Status update03/14/2023 8:46:10 PM
Last indexation05/02/2024 1:38:36 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack